Our NCI R01 research project grant was selected for funding and converted to a 7-year Method to Extend Research in Time under award number R37CA283575. This is a 2.5 million dollar total award for years 1-5 with an additional budget to be determined for years 6-7. We are immensely grateful for all the previous funding that provided the foundational preliminary data needed to secure this award.
Generous funding from the Tower Cancer Research Foundation will support our liver metastasis project
We are very humbled to receive this award from a truly inspiring cancer support and research foundation.
Our gemcitabine resistance work has received a Pilot Award from the California Cancer Research Consortium.
We are grateful for this generous funding to continue this work.
Chris received a Young Investigator in Pancreatology Award from the American Pancreatic Association
We are very grateful for this support to continue our work in pancreatic cancer cell heterogeneity.
Alica’s gemcitabine resistance review is out
If you want to know more about chemoresistance to gemcitabine in pancreatic cancer, look no further. You will also find some great figures to use for your future talk needs here: https://journals.physiology.org/doi/full/10.1152/ajpcell.00331.2022?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org